Next Score View the next score

    mass. movers

    Alkermes cites positive results

    A self-help psychological course in London.
    Associated Press/File 2013
    A self-help psychological course in London.

    Alkermes PLC reported data that suggest its drug for major depressive disorder in patients who don’t respond well to standard therapies will work. ALKS 5461 produced statistically significant improvement on three rating scales, compared to a placebo. A press release said ALKS 5461 reflects a new approach “based on modulation of opioid receptors in the brain and is designed as a non-addictive, oral, once-daily medicine.” Based in Ireland, Alkermes has a research center in Waltham.